Browsing "Hematology-Oncology" by Keyword : Disease Progression

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 11 of 11

Pub YearTitleAuthor(s)
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)강석윤, 최진혁
2015A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.정성현
2011Acquisition of a BCR-ABL1 transcript in a patient with disease progression from MDS with fibrosis to AML with myelodysplasia-related changes.김현주, 김효철, 박준성, 이현우, 정성현, 조성란
2012Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study이현우
2015Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁
2021Lineage switch of B-lymphoblastic leukemia into acute myeloid leukemia with residual lymphoblasts in a patient with previous breast cancer박서진, 조성란, 최용원, 한재호
2016Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)정성현
2007Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.-
2021Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)강석윤
2016Prognostic value of negative interim 2-[(1)(8)F]-fluoro-2-deoxy-d-glucose PET/CT in diffuse large B-cell lymphoma강대용, 안영실, 윤준기, 이수진, 이현우, 정성현
1997Relationship between p53 overexpression and gastric cancer progression.최진혁
1

Browse